Although the studies described on this Web site may have potential benefit as described, Stanford and its physicians and affiliated hospitals cannot and do not guarantee or promise that you will receive any benefits from participating in a study.
The faculty of the Clinical Cancer Center at Stanford are engaged in
a broad spectrum of clinical trials, which number over 250, and range
from diagnostics to treatment and prevention. Most of these studies test
the effectiveness of new cancer therapy, including new cancer chemotherapeutics
and drug modifiers, innovative radiotherapeutic approaches, monoclonal
antibodies, vaccines, and multidisciplinary treatments. Faculty collaborate
closely with basic scientists and epidemiologists, as well as faculty
in radiology, pathology, and other fields.
Research
is supported through the National Cancer Institute, American Cancer Society,
California Cancer Research Council, pharmaceutical grants, gifts, and
other funding sources.
Physicians with specific questions can contact the Clinical Trials Office at Stanford. For patients, the National Cancer Institute has more information about the purpose and nature of clinical research
at its Cancer Trials site.
Research
is supported through the National Cancer Institute, American Cancer Society,
California Cancer Research Council, pharmaceutical grants, gifts, and
other funding sources.